A carregar...
Natalizumab in pediatric multiple sclerosis patients
Pediatric multiple sclerosis (MS) comprises 2–5% of all cases of MS. Although first-line disease-modifying therapy (DMT) including interferons and glatiramer acetate appear to be well tolerated in this population, recent work has suggested that a growing number of children suffer from disease which...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3002661/ https://ncbi.nlm.nih.gov/pubmed/21179619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285610381526 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|